A recent analysis by InsightAce Analytic forecasts the anti-aging therapeutics market to expand significantly by 2030. Driven by rising demand for regenerative medicine, the report details mechanisms like senolytics and mTOR inhibitors. This provides a clear use case for stakeholders, illustrating how emerging treatments can meet age-related health challenges.
Q&A
- What drives market growth?
- How do clinical advances impact the market?
- What role do strategic partnerships play?
